8-K
filed January 19, 2023, 6:59 PM ET
ticker MODD
CIK 0001074871
other material
confidence high
sentiment neutral
materiality 0.15
Shareholders elect all 7 directors and approve 2M-share equity plan increase
Modular Medical, Inc.
- All seven director nominees elected: DiPerna, Febbo, Felsher, Frank, Sheibley, Volkart, O'Connor Vos.
- Amendment to 2017 Equity Plan adding 2M shares approved: 6,135,990 for, 156,846 against.
- Farber Hass Hurley LLP ratified as auditor for FY2023: 7,814,759 for, 39 against.
- Non-binding advisory vote on executive compensation passed; three-year frequency recommended (5,664,961 votes).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Modular Medical, Inc. shareholders approved Approval of one or more adjournments of the Annual Meeting at the 2023-01-17 meeting.
- Outcome
- passed
- Meeting
- 2023-01-17
Exact text from the filing
Proposal 6 – Approval of one or more adjournments of the Annual Meeting. For Against Abstain Broker Non-Vote 7,659,802 155,549 167 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Modular Medical, Inc. shareholders approved Recommendation, on a non-binding advisory basis, on the frequency of future advisory votes on the compensation of the Company’s named executive officers at the 2023-01-17 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-01-17
Exact text from the filing
Proposal 4 – Recommendation, on a non-binding advisory basis, on the frequency of future advisory votes on the compensation of the Company’s named executive officers. One Year Two Years Three Years Abstain 671,818 4,799 5,664,961 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Modular Medical, Inc. shareholders approved Election of directors to serve until the next annual meeting of shareholders at the 2023-01-17 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-01-17
Exact text from the filing
Proposal 1 – Election of directors to serve until the next annual meeting of shareholders. For Withheld Broker Non-Vote Paul DiPerna 6,316,874 24,074 1,473,940 William Febbo 6,223,061 118,517 1,473,940 Steven Felsher 6,085,541 256,037 1,473,940 Morgan Frank 6,316,874 24,074 1,473,940 Philip Sheibley 6,337,468 4,110 1,473,940 Carmen Volkart 6,232,034 109,544 1,473,940 Ellen O’Connor Vos 6,060,874 280,704 1,473,940
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Modular Medical, Inc. shareholders approved Ratification of the audit committee’s appointment of Farber Hass Hurley LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2023 at the 2023-01-17 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-01-17
Exact text from the filing
Proposal 5 – Ratification of the audit committee’s appointment of Farber Hass Hurley LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2023. For Against Abstain Broker Non-Vote 7,814,759 39 720 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Modular Medical, Inc. shareholders approved Amendment of the Amended 2017 Equity Incentive Plan to increase the number of shares currently reserved for issuance thereunder by 2,000,000 shares at the 2023-01-17 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-01-17
Exact text from the filing
Proposal 2 – Amendment of the Amended 2017 Equity Incentive Plan to increase the number of shares currently reserved for issuance thereunder by 2,000,000 shares. For Against Abstain Broker Non-Vote 6,135,990 156,846 48,742 1,437,940
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Modular Medical, Inc. shareholders approved Approval, on an advisory basis, of the executive compensation of the Company's named executive officers at the 2023-01-17 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-01-17
Exact text from the filing
Proposal 3 – Approval, on an advisory basis, of the executive compensation of the Company's named executive officers. For Against Abstain Broker Non-Vote 6,263,648 28,468 49,462 1,473,940
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.